First Ever 'Laser-Based' System for the Treatment of Cellulite
Improves Appearance, Local Circulation,
Relieves Minor Pain and Muscle Spasms
Improves Appearance, Local Circulation,
Relieves Minor Pain and Muscle Spasms
Chelmsford, MA (April 27, 2005)---Cynosure, Inc., a leading developer and manufacturer of cosmetic and medical lasers, announced today that it has received a new FDA clearance for the TriActive LaserDermology System, a laser-based system for treating cellulite. The new FDA clearance classifies the System as a Class II over the counter device. Laser-based medical devices typically require restricted use by or directed use by a physician. However, due to its safety characteristics, the TriActive has been cleared for use by non-physicians such as aestheticians, spa professionals, and other therapists.
The TriActive combines distinct technologies, including lasers, for treatment:
- Six low-energy diode lasers, which enhance microcirculation
- Mechanical massage, which stimulates and tightens the subcutaneous tissue
Aestheticians and therapists at spas and cellulite centers as well as aesthetic medicine physicians who use the TriActive report that using the laser over a series of treatments in conjunction with massage, is more effective in treating cellulite than massage alone.
"A recent study conducted at our center, showed that the TriActive laser and massage components improved the appearance of cellulite in 83% of subjects as compared to 17% improvement for massage only", said Kathryn Frew, MD, of the JUVA Skin and Laser Center in New York City.In addition to temporarily improving the appearance of cellulite, TriActive treatments have also been shown to temporarily relieve minor pain and muscle spasms, improve circulation and be used in conjunction with liposuction and other plastic surgery procedures.
"We now offer the TriActive LaserDermology System throughout North America. Originally developed by laser scientists in Italy, it has been in use worldwide for the past four years," said Michael R. Davin, Cynosure's CEO. "It compliments the other products in our cosmetic laser line and helps us better serve our markets, which include the thousands of aesthetic medicine practices and the more than 6000 day spas in the United States who do not necessarily have an associated physician relationship."
The term 'cellulite' refers to the dimpled appearance of the skin that occurs on hips, thighs, and buttocks. This appearance is much more common in women due to the differences in the way fat, muscle, and connective tissue are distributed in men and women's skin. The American Academy of Dermatology reports that at least 80 percent of women have cellulite. Currently more than 45 million women in the U.S. between the ages of 20 and 50 suffer from this condition and many seek treatment.
For more information on the TriActive, call Cynosure at 800-886-2966 and visit www.cynosurelaser.com.
About Cynosure Inc.
Cynosure, Inc. develops, manufactures, and markets laser and pulsed-light technology products for the surgical, medical and aesthetic marketplace for worldwide distribution. The company produces an extensive line of products for laser hair removal, the treatment of cellulite, facial and leg veins, pigmented and vascular lesions, sun damaged skin and surgical ENT applications. The Company was founded in 1991 and has laser installations in over 64 countries.